Cinnamaldehyde and cinnamaldehyde-containing micelles induce relaxation of isolated porcine coronary arteries: Role of nitric oxide and calcium

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2557-2566

  Rraffai, Gábor ^a   Kim, Byungkuk ^a   Park, Sanga ^a   Khang, Gilson ^a   Llee, Dongwon ^a   Vanhoutte, Paul M ^a,b  

^a Chonbuk National University   (South Korea)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Calcium sensitivity; Cinnamaldehyde; Micelle forming polymeric prodrug; NO synthase; Porcine coronary artery

Indexed keywords

CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CINNAMALDEHYDE; GUANYLATE CYCLASE; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLY(CINNAMALDEHYDE); PROSTAGLANDIN SYNTHASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG; VASODILATOR AGENT; ACROLEIN; EMULSION; MICELLE; NITRIC ACID;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; MICELLE; NONHUMAN; SWINE; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DRUG EFFECTS; EMULSION; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ACROLEIN; ANIMALS; CALCIUM; CORONARY VESSELS; EMULSIONS; IN VITRO TECHNIQUES; MICELLES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC ACID; SWINE; VASODILATION; VASODILATOR AGENTS;

EID: 84901344685     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S56578     Document Type: Article

References (44)

1. Vriens J, Nilius B, Vennekens R. Herbal compounds and toxins modulating TRP channels. Curr Neuropharmacol. 2008;6(1):79-96.
2. Meena V, Sree Satya N, Surya Prakash DV, Sumanjali A. A review on pharmacological activities and clinical effects of cinnamon species. Res J Pharm Biol Chem Sci. 2012;3(1):653-663.
3. Huang J, Wang S, Luo X, Xie Y, Shi X. Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents. Thromb Res. 2007;119(3):337-342.
4. Huss U, Ringbom T, Perera P, Bohlin L, Vasänge M. Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. J Nat Prod. 2002;65(11):1517-1521.
5. Lee HS, Kim BS, Kim MK. Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase. J Agric Food Chem. 2002;50(26):7700-7703.
6. Kwon HK, Jeon WK, Hwang JS, etal. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells. Cancer Lett. 2009;278(2):174-182.
7. Gowder SJ, Devaraj H. Effect of the food flavour cinnamaldehyde on the antioxidant status of rat kidney. Basic Clin Pharmacol Toxicol. 2006;99(5):379-382.
8. Subash Babu P, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde-a potential antidiabetic agent. Phytomedicine. 2007;14(1):15-22.
9. Zhang W, Xu YC, Guo FJ, Meng Y, Li ML. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin Med J (Engl). 2008;121(21):2124-2128.
10. Tamura Y, Iwasaki Y, Narukawa M, Watanabe T. Ingestion of cinnamaldehyde, a TRPA1 agonist, reduces visceral fats in mice fed a high-fat and high-sucrose diet. J Nutr Sci Vitaminol (Tokyo). 2012;58(1):9-13.
11. Harada M, Yano S. Pharmacological studies on Chinese cinnamon. II. Effects of cinnamaldehyde on the cardiovascular and digestive systems. Chem Pharm Bull (Tokyo). 1975;23(5):941-947.
12. Xu M, Yu L, Ding YY, Wang YM, Wang SW, Pei JM. [Experimental study on hypotensive effects of cinnamaldehyde in anesthetized rats]. Chinese Heart J. 2006;18(3):272-276. Chinese.
13. Pozsgai G, Bodkin JV, Graepel R, Bevan S, Andersson DA, Brain SD. Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc Res. 2010;87(4):760-768.
14. Yanaga A, Goto H, Nakagawa T, Hikiami H, Shibahara N, Shimada Y. Cinnamaldehyde induces endothelium-dependent and-independent vasorelaxant action on isolated rat aorta. Biol Pharm Bull. 2006;29(12): 2415-2418.
15. Xue YL, Shi HX, Murad F, Bian K. Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc Health Risk Manag. 2017:273-280.
16. El-Bassossy HM, Fahmy A, Badawy D. Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem Toxicol. 2011;49(11):3007-3012.
17. Yuan JH, Dieter MP, Bucher JR, Jameson CW. Toxicokinetics of cinnamaldehyde in F344 rats. Food Chem Toxicol. 1992;30(12):997-1004.
18. Kim B, Lee E, Kim Y, Park S, Khang G, Lee D. Dual acid-responsive micelle-forming anticancer polymers as new anticancer therapeutics. Adv Functional Mater. 2013;23(40):5091-5097.
19. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288(5789):373-376.
20. McNamara CR, Mandel-Brehm J, Bautista DM, etal. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A. 2007;104(33): 13525-13530.
21. Nagata K, Duggan A, Kumar G, García-Añoveros J. Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci. 2005;25(16):4052-4061.
22. Macpherson LJ, Hwang SW, Miyamoto T, Dubin AE, Patapoutian A, Story GM. More than cool: promiscuous relationships of menthol and other sensory compounds. Mol Cell Neurosci. 2006;32(4):335-343.
23. Campos Rosa J, Galanakis D, Piergentili A, etal. Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca(2+)-activated K(+) channel. J Med Chem. 2000;43(3):420-431.
24. Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A. 2000;97(14):8151-8156.
25. Galvez A, Gimenez-Gallego G, Reuben JP, etal. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 1990;265(19):11083-11090.
26. Schmid-Antomarchi H, De Weille J, Fosset M, Lazdunski M. The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. J Biol Chem. 1987;262(33):15840-15844.
27. Bandell M, Story GM, Hwang SW, etal. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 2004;41(6):849-857.
28. Bodkin JV, Brain SD. Transient receptor potential ankyrin 1: emerging pharmacology and indications for cardiovascular biology. Acta Physiol (Oxf). 2011;203(1):87-98.
29. Earley S, Brayden JE. Transient receptor potential channels and vascular function. Clin Sci (Lond). 2010;119(1):19-36.
30. Di A, Malik AB. TRP channels and the control of vascular function. Curr Opin Pharmacol. 2010;10(2):127-132.
31. Vennekens R. Emerging concepts for the role of TRP channels in the cardiovascular system. J Physiol. 2011;589(Pt 7):1527-1534.
32. Watanabe H, Murakami M, Ohba T, Takahashi Y, Ito H. TRP channel and cardiovascular disease. Pharmacol Ther. 2008;118(3):337-351.
33. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87(1):165-217.
34. Earley S. TRPA1 channels in the vasculature. Br J Pharmacol. 2012; 167(1):13-22.
35. Fajardo O, Meseguer V, Belmonte C, Viana F. TRPA1 channels: novel targets of 1,4-dihydropyridines. Channels (Austin). 2008;2(6):429-438.
36. Ogawa H, Takahashi K, Miura S, etal. H(2)S functions as a nociceptive messenger through transient receptor potential ankyrin 1 (TRPA1) activation. Neuroscience. 2012;218:335-343.
37. Earley S, Gonzales AL, Crnich R. Endothelium-dependent cerebral artery dilation mediated by TRPA1 and Ca2+-Activated K+ channels. Circ Res. 2009;104(8):987-994.
38. Nobe K, Paul RJ. Distinct pathways of Ca(2+) sensitization in porcine coronary artery: effects of Rho-related kinase and protein kinase C inhibition on force and intracellular Ca(2+). Circ Res. 2001;88(12):1283-1290.
39. Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature. 1983;303(5917):535-527.
40. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol. 1995;48(2):184-188.
41. Krishna CM, Liebmann JE, Kaufman D, et al. The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. Arch Biochem Biophys. 1992;294(1):98-106.
42. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, Kirkman HN. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood. 1996;87(4):1595-1599.
43. Matoba T, Shimokawa H, Nakashima M, etal. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000;106(12):1521-1530.
44. Matoba T, Shimokawa H, Morikawa K, etal. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol. 2003;23(7):1224-1230.